Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “recombinant”

322 pharma patents match "recombinant" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 322
Index total 30,257
Page 8 / 14

Quick answer

This filtered view shows 322 pharmaceutical patents matching "recombinant" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

322 results for “recombinant” · 30,257 patents in full index Clear search

  1. US 8426188

    Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof

    The Board of Regents of the University of Texas System · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted
  2. US 8394387

    Recombinant modified Bacillus anthracis protective antigen for use in vaccines

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted
  3. US 8383132

    Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use

    The Regents of the University of California · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  4. US 8367074

    Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  5. US 8361733

    Methods of identifying modulators of a cold-and-menthol-sensitive receptor (CMR1) and recombinant cells for use thereof

    The Regents of the University of California · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  6. US 8323634

    Stable formulations of highly concentrated recombinant human albumin-human granulocyte colony stimulating factor

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  7. US 8287879

    Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use

    The Regents of the University of California · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  8. US 8287876

    Recombinant chimeric antigens for diagnosis and prevention of scrub typhus

    United States of America as represented by the Secretary of the Air Force · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  9. US 8211447

    Recombinant P. falciparum merozoite protein-142 vaccine

    The United States of America as represented by the Secretary of the Army · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted
  10. US 8163548

    Recombinant bicistronic flaviviruses and methods of use thereof

    The Regents of the University of California · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  11. US 8163294

    Growth regulatable recombinant BCG compositions

    The Regents of the University of California · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  12. US 8142787

    Recombinant chimeric antigens for diagnosis and prevention of scrub typhus

    United States of America as represented by the Secretary of the Air Force · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  13. US 8124068

    Recombinant intracellular pathogen immunogenic compositions and methods of use

    The Regents of the University of California · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted
  14. US 8119769

    Complement depletion using recombinant human C-3 derivatives

    PLS-Design GmbH · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  15. US 8101739

    Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vector

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  16. US 8039003

    Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted
  17. US 8029804

    Recombinant chimeric antigens for diagnosis and prevention of scrub typhus

    United States of America as represented by the Secretary of the Air Force · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted
  18. US 8012699

    Recombinant antigens for diagnosis and prevention of murine typhus

    United States of America as represented by the Secretary of the Air Force · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted
  19. US 8012490

    Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted
  20. US 7960535

    Recombinant lipidated PsaA protein, methods of preparation and use

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  21. US 7928194

    Recombinant antigen for diagnosis and prevention of murine typhus

    United States of America as represented by the Secretary of the Air Force · Granted Apr 19, 2011 · Expires Apr 14, 2031

    granted
  22. US 7923535

    Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 12, 2011 · Expires Apr 7, 2031

    granted
  23. US 7919301

    Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted
  24. US 7871814

    Recombinant bicistronic flaviviruses and methods of use thereof

    The Regents of the University of California · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted